LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Product Focus Histogenics specializes in personalized restorative cell therapies with NeoCart targeting knee cartilage regeneration, presenting opportunities to connect with healthcare providers and clinics specializing in regenerative medicine and osteoarthritis treatment.

Regulatory Engagement The company is actively working through the FDA regulatory pathway for NeoCart, indicating potential for upcoming product launches and opportunities for partnerships with medical device distributors and orthopedic specialists.

Strategic Mergers Since merging with Ocugen, Histogenics has strengthened its market position, opening avenues to collaborate with biotech and pharma entities interested in innovative regenerative therapies.

Market Expansion Recent licensing agreements, notably in Japan, showcase growth ambitions internationally, suggesting opportunities to expand distribution channels and partner with regional biotech firms or healthcare providers.

Financial Outlook With revenue estimates between $10M and $25M and recent stock market gains, there are prospects for investors or partners interested in early-stage biotech companies with promising regenerative treatment pipelines.

Similar companies to Histogenics Corporation

Histogenics Corporation Tech Stack

Histogenics Corporation uses 8 technology products and services including SiteCatalyst, Comscore, Drupal, and more. Explore Histogenics Corporation's tech stack below.

  • SiteCatalyst
    Analytics
  • Comscore
    Analytics
  • Drupal
    Content Management System
  • Twemoji
    Font Scripts
  • TweenMax
    Javascript Frameworks
  • Backbone.js
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • Google Analytics
    Web Analytics

Media & News

Histogenics Corporation's Email Address Formats

Histogenics Corporation uses at least 1 format(s):
Histogenics Corporation Email FormatsExamplePercentage
FLast@histogenics.comJDoe@histogenics.com
85%
Last@histogenics.comDoe@histogenics.com
9%
LFirst@histogenics.comDJohn@histogenics.com
4%
FirstLast@histogenics.comJohnDoe@histogenics.com
2%

Frequently Asked Questions

What is Histogenics Corporation's phone number?

Minus sign iconPlus sign icon You can contact Histogenics Corporation's main corporate office by phone at
+1-781-547-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Histogenics Corporation's official website and social media links?

Minus sign iconPlus sign iconHistogenics Corporation's official website is histogenics.com and has social profiles on LinkedInCrunchbase.

What is Histogenics Corporation's SIC code NAICS code?

Minus sign iconPlus sign iconHistogenics Corporation's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Histogenics Corporation have currently?

Minus sign iconPlus sign iconAs of July 2026, Histogenics Corporation has approximately 10 employees across 1 continents, including North America. Key team members include Chief Financial Officer: K. M.Consultant: R. C.. Explore Histogenics Corporation's employee directory with LeadIQ.

What industry does Histogenics Corporation belong to?

Minus sign iconPlus sign iconHistogenics Corporation operates in the Biotechnology Research industry.

What technology does Histogenics Corporation use?

Minus sign iconPlus sign iconHistogenics Corporation's tech stack includes SiteCatalystComscoreDrupalTwemojiTweenMaxBackbone.jsModernizrGoogle Analytics.

What is Histogenics Corporation's email format?

Minus sign iconPlus sign iconHistogenics Corporation's email format typically follows the pattern of FLast@histogenics.com. Find more Histogenics Corporation email formats with LeadIQ.

How much funding has Histogenics Corporation raised to date?

Minus sign iconPlus sign icon As of July 2026, Histogenics Corporation has raised $227M in funding. The last funding round occurred on Oct 05, 2018 for $17M.

When was Histogenics Corporation founded?

Minus sign iconPlus sign iconHistogenics Corporation was founded in 2000.
Histogenics Corporation logo

Histogenics Corporation

Biotechnology ResearchMassachusetts, United States2-10 Employees

Histogenics is a biotechnology research company based in Waltham, Massachusetts, focused on personalized restorative cell therapies for active living. Its leading candidate, NeoCart, is designed to reconstruct a patient's knee cartilage using a patient-specific approach, with the aim of reducing pain at the source and potentially slowing progression to osteoarthritis. The work centers on regenerating tissue within the joint to restore function rather than merely managing symptoms.

Histogenics serves patients with knee joint damage who may benefit from cartilage restoration, operating within the biotech research sector. In 2019, the company was acquired by Ocugen, integrating its work into a broader organization. The firm has a small team and continues development activities related to NeoCart.

Section iconCompany Overview

Phone number
+1-781-547-****
Website
histogenics.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $227M

    Histogenics Corporation has raised a total of $227M of funding over 7 rounds. Their latest funding round was raised on Oct 05, 2018 in the amount of $17Mas a post_ipo_equity.

  • $10M$25M

    Histogenics Corporation's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $227M

    Histogenics Corporation has raised a total of $227M of funding over 7 rounds. Their latest funding round was raised on Oct 05, 2018 in the amount of $17Mas a post_ipo_equity.

  • $10M$25M

    Histogenics Corporation's revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    K. M.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. C.
    Consultant
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.